Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-06-03

Clinical Trial Update: Topical Allstate and Nasal Allergen Challenge [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating topical Allstate and a nasal allergen challenge for allergic rhinitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nasal allergen challenge
  • Topical Allstate

Snippet

Sponsor: University of Chicago | Conditions: Allergic Rhinitis | Phase 3 | Status: WITHDRAWN